Delighted to be part of iMATCH
A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses.
Manchester is one of only three centres in Britain awarded funding by Innovate UK, from the Industrial Strategy Challenge Fund, to coordinate a strategy to scale-up advanced therapies for a range of debilitating conditions. The centre, hosted at The Christie, will design and run larger clinical trials in this innovative area of personalised medicine.
There are no comments on this post yet. Be the first to leave a comment.